It depends on the drug, however while I can’t find the article again with a quick search at work, a few days ago I read this specific drug takes an entire team/lab months to create just around a dozen doses.
Until we’re able to make this more efficient, producing each dose will probably be a large part of the cost when taking into account the salaries/costs of all the staff involved. The fact that hemophilia b is quite rare (I think 1 in 25,000 people) will also often lead to a higher cost.
Regardless, this is an amazing step forward in the fight against a horrible blood disorder.
CdnAevyn t1_ixvkamn wrote
Reply to comment by GratefulOctopus in A novel medication for hemophilia B has just been approved by the Food and Drug Administration. The treatment is a form of gene therapy, intended to replace a dysfunctional gene that leaves people unable to control their bleeding. by Sariel007
It depends on the drug, however while I can’t find the article again with a quick search at work, a few days ago I read this specific drug takes an entire team/lab months to create just around a dozen doses.
Until we’re able to make this more efficient, producing each dose will probably be a large part of the cost when taking into account the salaries/costs of all the staff involved. The fact that hemophilia b is quite rare (I think 1 in 25,000 people) will also often lead to a higher cost.
Regardless, this is an amazing step forward in the fight against a horrible blood disorder.